Clinical Data Analyst

Clinical Data Analyst (Cell Therapy) Greater São Paulo Area / Hybrid Our 3 Core Values - Intelligence - Integrity - Initiative Our mission is to harness the immune system through innovative cell therapies and other modalities to deliver widely accessible cures. Patients are waiting What You'll Do - Conduct data entry, data review checks and query management of trial data; - Assistwith review of data quality and with completing actions that arise from Data Quality Control checks; - Provide guidance to site investigators on how to complete relevant forms and use the Data Management Systems; - Check and identifying problems with data received from trial sites, escalating any data concerns as appropriate, including Adverse Event (AE) coding; - Liaisewith site investigators and trial teams to resolve data queries and problematic data under the supervision of the Data Manager and in line with written procedures; - Conduct checks of all data received by site investigators in line with written procedures, to ensure compliance with the trial protocol and data collection guidance; - Handleand storing data and relevant documentation in line with written procedures, ICH GCP and General Data Protection Regulation (GDPR); - Test and document the trial and Data Management systems, in line with written procedures; To assist Data - Ensure all data and documentation are readily accessible for independent audits and inspections; - Handleand store all data and corresponding communications per written procedures and in line with relevant regulations, Good Clinical Practice (GCP) and General Data Protection Regulation (GDPR); - File important trial documents in the Trial Master File (TMF) and assist with archiving as per written procedures; What We Look For: - Bachelor's degree - At least 1 year of working experience in Clinical data at a CRO or sponsor, 2+ years preferred - Proficient knowledge and practical utilization of ICH- GCP and applicable regulatory requirements. About Nexcella Nexcella Inc., a wholly-owned Immix Biopharma subsidiary, is a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other serious diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201. Learn more at